Immunome is a biopharmaceutical company utilizing our proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics ...
The Investor Relations website contains information about ImmunityBio, Inc.'s business for stockholders, potential investors, and financial analysts.
Immunome Reports Full Year 2023 Financial Results and Provides Update on Recently Acquired Assets ... Investor Alert Options * News Events & Presentations
Missing: immu | Show results with:immu
Investor Information. 02-27-24 ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 · April 2024 Corporate ...
The Investor Relations website contains information about Immunocore PLC's business for stockholders, potential investors, and financial analysts.
Missing: immu | Show results with:immu
Immunic Therapeutics Jessica Breu Vice President Investor Relations and Communications +49 89 2080 477 09 jessica.breu@imux.com. Rx Communications Paula ...
Missing: immu | Show results with:immu
Events & Presentations ; 42nd Annual J.P. Morgan Healthcare Conference. Jan 8 - Jan 11, 2024. Location. San Francisco, California ; Piper Sandler Annual ...
Investor Relations. Immunovant, Inc. Chau Cheng, Ph.D., M.B.A.. Investor Relations info@immunovant.com. Transfer Agent. Continental Stock Transfer & Trust ...
Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for ...
People also ask
Who are the investors in Ibrx?
Who is the CEO of immunome?
Home | Investors | Annual Reports. Download our Annual Reports. Annual Report 2022 · Annual Report 2021 · Annual Report 2020 · Annual Report 2019.